Figure 1.

Correlation between MBC diagnosed in Western and Asian countries and outcome. (A) Comparison of breast cancer-specific survival (BCSS) of patients with metaplastic breast carcinoma diagnosed Asian countries (upper green curve; 88 patients) and Western countries (lower blue curve; 197 patients) as compared with the control group of conventional ductal carcinoma (middle grey curve; 285 patients) (X²=12.1, DF=2, P=0.002). (B) Comparison of BCSS of same groups after exclusion of locally advanced cases (tumours >stage T2); Asian patients (upper green curve; 63 patients) and Western patients (lower blue curve; 145 patients as compared with the control group of conventional ductal carcinoma (middle grey curve; 285 patients) (X²=2.9, DF=2, P=0.237). A full color version of this figure is available at the British Journal of Cancer journal online.